Ameriprise’s NovaBridge Biosciences American Depositary Shares NBP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-12,859
Closed -$609K 3982
2021
Q4
$609K Sell
12,859
-3,606
-22% -$216K ﹤0.01% 3445
2021
Q3
$1.19M Buy
+16,465
New +$1.19M ﹤0.01% 3092

Other funds holding NBP

Ameriprise's NBP Position: Q1 2022 in Review

Ameriprise sold out of NovaBridge Biosciences American Depositary Shares (NBP) in Q1 2022, closing a stake of 12,859 shares — an estimated $609K sold.

Ameriprise first reported a position in NBP in Q3 2021 and held it in 2 quarters. The position peaked at $1.19M in Q3 2021. 120 funds tracked by Wall St. Rank hold NBP as of Q1 2022.

  • Ameriprise reported no remaining NovaBridge Biosciences American Depositary Shares position as of Q1 2022 after selling out during the quarter.
  • Ameriprise sold 12,859 NovaBridge Biosciences American Depositary Shares shares in Q1 2022, an estimated $609K.
  • Ameriprise first reported a position in NovaBridge Biosciences American Depositary Shares in Q3 2021 and held it in 2 quarters.
  • Ameriprise's NovaBridge Biosciences American Depositary Shares position peaked at $1.19M in Q3 2021.
  • 120 funds tracked by Wall St. Rank held NovaBridge Biosciences American Depositary Shares as of Q1 2022.

Based on Ameriprise's 13F filing for Q1 2022, filed 16 May 2022.